San Clemente-based Cameron Health, a maker of subcutaneous, implantable cardiac defibrillators, has been acquired by Boston Scientific, in a deal worth $150M in cash, plus up to $150M on FDA approval of Cameron Health's product, plus up to an additional $1.050 billion in earnout. Cameron Health's implantable defibrillator improves upon existing, implantable defibrillators in that it does not require implanting thin, insulated leads to be inserted into the heart. Instead, the firm's entire system sits below the skin and does not require touching the heart or blood vessels. Cameron Health was venture backed by Alloy Ventures, Boston Scientific, Delphi Ventures, PTV Sciences, Sorrento Ventures, Three Arch Partners, and Versant Ventures. The firm's last announced round was in May of 2011, and was worth $107M.
Top NewsFriday, March 9, 2012
Cameron Health Acquired By Boston Scientific